ATOSSA THERAPEUTICS, INC. Share-based Payment Arrangement, Expense
ATOSSA THERAPEUTICS, INC. (ATOS) reported Share-based Payment Arrangement, Expense of $815.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-07
- ATOSSA THERAPEUTICS, INC. share-based payment arrangement, expense for the quarter ending 2026-06-30 was $815.00K, a 2.39% increase year-over-year.
- ATOSSA THERAPEUTICS, INC. share-based payment arrangement, expense for the quarter ending 2026-03-31 was $722.00K, a 28.24% increase year-over-year.
- ATOSSA THERAPEUTICS, INC. share-based payment arrangement, expense for the quarter ending 2025-12-31 was $503.00K, a 35.01% decline year-over-year.
- ATOSSA THERAPEUTICS, INC. share-based payment arrangement, expense for the quarter ending 2025-09-30 was $784.00K, a 4.67% increase year-over-year.
- ATOSSA THERAPEUTICS, INC. share-based payment arrangement, expense for fiscal 2025 was $2.65M, a 15.45% increase from fiscal 2024.
- ATOSSA THERAPEUTICS, INC. share-based payment arrangement, expense for fiscal 2024 was $2.29M, a 50.40% decline from fiscal 2023.
- ATOSSA THERAPEUTICS, INC. share-based payment arrangement, expense for fiscal 2023 was $4.62M, a 31.92% decline from fiscal 2022.
- ATOSSA THERAPEUTICS, INC. share-based payment arrangement, expense for fiscal 2022 was $6.79M, a 28.88% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 3 month as first filed | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 6 month as first filed | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 9 month as first filed | Share-based Payment Arrangement, Expense 12 month | Share-based Payment Arrangement, Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $815.00K 10-Q · filed 2026-08-07 | $1.54M 10-Q · filed 2026-08-07 | $2.04M derived: sum of 3 quarters · filed 2026-08-07 | $2.82M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2026-03-31 | $722.00K 10-Q · filed 2026-05-08 | $1.23M derived: sum of 2 quarters · filed 2026-05-08 | $2.01M derived: sum of 3 quarters · filed 2026-05-08 | $2.81M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-12-31 | $503.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $1.29M derived: sum of 2 quarters · filed 2026-03-25 | $2.08M derived: sum of 3 quarters · filed 2026-08-07 | $2.65M 10-K · filed 2026-03-25 | ||||
| 2025-09-30 | $784.00K 10-Q · filed 2025-11-12 | $1.58M derived: sum of 2 quarters · filed 2026-08-07 | $2.14M 10-Q · filed 2025-11-12 | $2.92M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-06-30 | $796.00K 10-Q · filed 2026-08-07 | $1.36M 10-Q · filed 2026-08-07 | $2.13M derived: sum of 3 quarters · filed 2026-08-07 | $2.88M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-03-31 | $563.00K 10-Q · filed 2026-05-08 | $1.34M derived: sum of 2 quarters · filed 2026-05-08 | $2.09M derived: sum of 3 quarters · filed 2026-05-08 | $2.44M derived: sum of 4 quarters · filed 2026-05-08 | ||||
| 2024-12-31 | $774.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $1.52M derived: sum of 2 quarters · filed 2026-03-25 | $1.88M derived: sum of 3 quarters · filed 2026-03-25 | $2.29M 10-K · filed 2026-03-25 | ||||
| 2024-09-30 | $749.00K 10-Q · filed 2025-11-12 | $1.10M derived: sum of 2 quarters · filed 2025-11-12 | $1.52M 10-Q · filed 2025-11-12 | $2.04M derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | $352.00K 10-Q · filed 2025-08-12 | $769.00K 10-Q · filed 2025-08-12 | $1.29M derived: sum of 3 quarters · filed 2025-08-12 | $2.21M derived: sum of 4 quarters · filed 2025-08-12 | ||||
| 2024-03-31 | $417.00K 10-Q · filed 2025-05-13 | $936.00K derived: sum of 2 quarters · filed 2025-05-13 | $1.86M derived: sum of 3 quarters · filed 2025-05-13 | $3.46M derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | $519.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25 | $1.45M derived: sum of 2 quarters · filed 2025-03-25 | $3.05M derived: sum of 3 quarters · filed 2025-03-25 | $4.62M 10-K · filed 2025-03-25 | ||||
| 2023-09-30 | $926.00K 10-Q · filed 2024-11-12 | $2.53M derived: sum of 2 quarters · filed 2024-11-12 | $4.10M 10-Q · filed 2024-11-12 | $5.65M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | $1.60M 10-Q · filed 2024-08-12 | $3.18M 10-Q · filed 2024-08-12 | $4.72M derived: sum of 3 quarters · filed 2024-08-12 | $6.39M derived: sum of 4 quarters · filed 2024-08-12 | ||||
| 2023-03-31 | $1.57M 10-Q · filed 2024-05-13 | $3.12M derived: sum of 2 quarters · filed 2024-05-13 | $4.78M derived: sum of 3 quarters · filed 2024-05-13 | $6.55M derived: sum of 4 quarters · filed 2024-05-13 | ||||
| 2022-12-31 | $1.54M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $3.21M derived: sum of 2 quarters · filed 2024-04-01 | $4.98M derived: sum of 3 quarters · filed 2024-04-01 | $6.79M 10-K · filed 2024-04-01 | ||||
| 2022-09-30 | $1.67M 10-Q · filed 2023-11-13 | $3.44M derived: sum of 2 quarters · filed 2023-11-13 | $5.24M 10-Q · filed 2023-11-13 | $6.86M derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | $1.77M 10-Q · filed 2023-08-14 | $3.58M 10-Q · filed 2023-08-14 | $5.20M derived: sum of 3 quarters · filed 2023-08-14 | $6.99M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $1.81M 10-Q · filed 2023-05-15 | $3.42M derived: sum of 2 quarters · filed 2023-05-15 | $5.22M derived: sum of 3 quarters · filed 2023-05-15 | $6.43M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | $1.62M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $3.41M derived: sum of 2 quarters · filed 2023-03-22 | $4.63M derived: sum of 3 quarters · filed 2023-03-22 | $5.27M 10-K · filed 2023-03-22 | ||||
| 2021-09-30 | $1.79M 10-Q · filed 2022-11-07 | $1.79M 10-Q · filed 2021-11-15 | $3.01M derived: sum of 2 quarters · filed 2022-11-07 | $3.65M 10-Q · filed 2022-11-07 | $3.65M 10-Q · filed 2021-11-15 | $4.28M derived: sum of 4 quarters · filed 2022-11-07 | ||
| 2021-06-30 | $1.21M 10-Q · filed 2022-08-08 | $1.21M 10-Q · filed 2021-08-13 | $1.85M 10-Q · filed 2022-08-08 | $1.85M 10-Q · filed 2021-08-13 | $2.49M derived: sum of 3 quarters · filed 2022-08-08 | $3.15M derived: sum of 4 quarters · filed 2022-08-08 | ||
| 2021-03-31 | $640.00K 10-Q · filed 2022-05-09 | $639.75K 10-Q · filed 2021-05-14 | $1.27M derived: sum of 2 quarters · filed 2022-05-09 | $1.93M derived: sum of 3 quarters · filed 2022-05-09 | $2.97M derived: sum of 4 quarters · filed 2022-05-09 | |||
| 2020-12-31 | $631.17K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $1.29M derived: sum of 2 quarters · filed 2022-02-28 | $2.33M derived: sum of 3 quarters · filed 2022-02-28 | $3.02M 10-K · filed 2022-02-28 | $3.02M 10-K · filed 2021-03-31 | |||
| 2020-09-30 | $663.59K 10-Q · filed 2021-11-15 | $1.70M derived: sum of 2 quarters · filed 2021-11-15 | $2.39M 10-Q · filed 2021-11-15 | $3.14M derived: sum of 4 quarters · filed 2021-11-15 | ||||
| 2020-06-30 | $1.04M 10-Q · filed 2021-08-13 | $1.72M 10-Q · filed 2021-08-13 | $2.48M derived: sum of 3 quarters · filed 2021-08-13 | $3.23M derived: sum of 4 quarters · filed 2021-08-13 | ||||
| 2020-03-31 | $687.75K 10-Q · filed 2021-05-14 | $1.44M derived: sum of 2 quarters · filed 2021-05-14 | $2.20M derived: sum of 3 quarters · filed 2021-05-14 | $7.51M derived: sum of 4 quarters · filed 2021-05-14 | ||||
| 2019-12-31 | $755.84K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $1.51M derived: sum of 2 quarters · filed 2021-03-31 | $6.83M derived: sum of 3 quarters · filed 2021-03-31 | $7.10M 10-K · filed 2021-03-31 | $7.10M 10-K · filed 2020-03-26 | |||
| 2019-09-30 | $751.65K 10-Q · filed 2020-11-13 | $6.07M derived: sum of 2 quarters · filed 2020-11-13 | $6.35M 10-Q · filed 2020-11-13 | $6.67M derived: sum of 4 quarters · filed 2020-11-13 | ||||
| 2019-06-30 | $5.32M 10-Q · filed 2020-08-13 | $5.59M 10-Q · filed 2020-08-13 | $5.92M derived: sum of 3 quarters · filed 2020-08-13 | $6.25M derived: sum of 4 quarters · filed 2020-08-13 | ||||
| 2019-03-31 | $275.83K 10-Q · filed 2020-05-13 | $603.08K derived: sum of 2 quarters · filed 2020-05-13 | $935.14K derived: sum of 3 quarters · filed 2020-05-13 | $1.11M derived: sum of 4 quarters · filed 2020-05-13 | ||||
| 2018-12-31 | $327.24K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $659.31K derived: sum of 2 quarters · filed 2020-03-26 | $838.36K derived: sum of 3 quarters · filed 2020-03-26 | $1.05M 10-K · filed 2020-03-26 | ||||
| 2018-09-30 | $332.06K 10-Q · filed 2019-11-13 | $511.11K derived: sum of 2 quarters · filed 2019-11-13 | $726.25K 10-Q · filed 2019-11-13 | |||||
| 2018-06-30 | $179.05K 10-Q · filed 2019-08-13 | $394.19K 10-Q · filed 2019-08-13 | ||||||
| 2017-12-31 | $226.18K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-28 | $450.44K derived: sum of 2 quarters · filed 2019-03-28 | $631.84K derived: sum of 3 quarters · filed 2019-03-28 | $786.55K 10-K · filed 2019-03-28 | ||||
| 2017-09-30 | $224.25K 10-Q · filed 2017-11-13 | $405.66K derived: sum of 2 quarters · filed 2017-11-13 | $560.37K 10-Q · filed 2017-11-13 | $786.50K derived: sum of 4 quarters · filed 2018-03-08 | ||||
| 2017-06-30 | $181.41K 10-Q · filed 2017-08-14 | $336.12K 10-Q · filed 2017-08-14 | $562.25K derived: sum of 3 quarters · filed 2018-03-08 | $819.64K derived: sum of 4 quarters · filed 2018-03-08 | ||||
| 2017-03-31 | $154.71K 10-Q · filed 2017-05-11 | $380.84K derived: sum of 2 quarters · filed 2018-03-08 | $638.23K derived: sum of 3 quarters · filed 2018-03-08 | $838.42K derived: sum of 4 quarters · filed 2018-03-08 | ||||
| 2016-12-31 | $226.14K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $483.52K derived: sum of 2 quarters · filed 2018-03-08 | $683.71K derived: sum of 3 quarters · filed 2018-03-08 | $876.19K 10-K · filed 2018-03-08 | ||||
| 2016-09-30 | $257.39K 10-Q · filed 2017-11-13 | $457.58K derived: sum of 2 quarters · filed 2017-11-13 | $650.05K 10-Q · filed 2017-11-13 | $786.41K derived: sum of 4 quarters · filed 2017-11-13 | ||||
| 2016-06-30 | $200.19K 10-Q · filed 2017-08-14 | $392.66K 10-Q · filed 2017-08-14 | $392.64K 10-Q/A · filed 2017-03-21 | $529.02K derived: sum of 3 quarters · filed 2017-08-14 | $847.01K derived: sum of 4 quarters · filed 2017-08-14 | |||
| 2016-03-31 | $192.46K 10-Q · filed 2017-05-11 | $328.83K derived: sum of 2 quarters · filed 2017-05-11 | $646.82K derived: sum of 3 quarters · filed 2017-05-11 | $851.93K derived: sum of 4 quarters · filed 2017-05-11 | ||||
| 2015-12-31 | $136.38K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2017-03-21 | $454.36K derived: sum of 2 quarters · filed 2017-03-21 | $659.48K derived: sum of 3 quarters · filed 2017-03-21 | $840.10K 10-K/A · filed 2017-03-21 | ||||
| 2015-09-30 | $317.99K 10-Q/A · filed 2017-03-21 | $523.10K derived: sum of 2 quarters · filed 2017-03-21 | $703.73K 10-Q/A · filed 2017-03-21 | $683.14K derived: sum of 4 quarters · filed 2017-03-21 | ||||
| 2015-06-30 | $205.11K 10-Q/A · filed 2017-03-21 | $353.98K 10-Q/A · filed 2017-03-21 | $385.74K 10-Q · filed 2015-08-06 | $365.15K derived: sum of 3 quarters · filed 2017-03-21 | $512.55K derived: sum of 4 quarters · filed 2017-03-21 | |||
| 2015-03-31 | $148.87K 10-Q/A · filed 2017-03-21 | $180.63K 10-Q · filed 2015-05-13 | $160.04K derived: sum of 2 quarters · filed 2017-03-21 | $307.44K derived: sum of 3 quarters · filed 2017-03-21 | $474.98K derived: sum of 4 quarters · filed 2017-03-21 | |||
| 2014-12-31 | $11.17K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $158.57K derived: sum of 2 quarters · filed 2016-03-30 | $326.11K derived: sum of 3 quarters · filed 2016-03-30 | $556.29K 10-K · filed 2016-03-30 | $698.66K 10-K · filed 2015-03-30 | |||
| 2014-09-30 | $147.40K 10-Q · filed 2015-11-12 | $314.93K derived: sum of 2 quarters · filed 2015-11-12 | $545.12K 10-Q · filed 2015-11-12 | |||||
| 2014-06-30 | $167.53K 10-Q · filed 2015-08-06 | $397.71K 10-Q · filed 2015-08-06 | ||||||
| 2014-03-31 | $230.18K 10-Q · filed 2015-05-13 | |||||||
| 2013-12-31 | $1.44M 10-K · filed 2015-03-30 | $140.06K 10-K · filed 2014-03-27 | ||||||
| 2012-12-31 | $1.44M 10-K · filed 2014-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |